Author:
Chen Shimin,Hu Shangying,Yin Jian,Yu Wenying,Zhang Xun,Deng Xi,Ding Huaxin,Zhang Jinyu,Song Yan,Wang Qiming,Chen Liang,Guo Feng,Hartwig Susanne,Zhao Fanghui
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Lei J, Ploner A, Elfstrom KM, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383:1340–8.
2. Mix JM, Van Dyne EA, Saraiya M, et al. Assessing impact of HPV vaccination on cervical cancer incidence among women aged 15–29 years in the United States, 1999–2017: an ecologic study. Cancer Epidemiol Biomarkers Prev. 2021;30:30–7.
3. Kjaer SK, Dehlendorff C, Belmonte F, Baandrup L. Real-world effectiveness of human papillomavirus vaccination against cervical cancer. J Natl Cancer Inst. 2021;113:1329–35.
4. Ronco G, Dillner J, Elfstrom KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383:524–32.
5. Zhang J, Zhao Y, Dai Y, et al. Effectiveness of high-risk human papillomavirus testing for cervical cancer screening in china: a multicenter, open-label. Randomized Clinical Trial JAMA Oncol. 2021;7:263–70.